Peter Sander

Peter Sander is a Full Professor at the University of Zurich, leading the Institute of Medical Microbiology's research group focused on Mycobacterium tuberculosis and Mycobacterium abscessus. His research spans virulence mechanisms, lipoprotein biogenesis, vaccine innovation, and antibiotic resistance.

Key research areas include

• Posttranslational modification of mycobacterial lipoproteins
• Drug susceptibility and resistance mechanisms
• RNA metabolism as antibiotic target

Recent publications highlight advancements in 3',6'-disubstituted spectinomycins for efflux resistance, Fidaxomicin derivatives with enhanced activity, and Mycobacterium abscessus resistance gene characterization. Collaborations span institutions in Switzerland, France, Italy, and the U.S.

Scientific honors include the

• Young Investigator Award

from the German Society for Hygiene and Microbiology (2002). Supported by grants from the Swiss National Science Foundation, European Commission, and industry partners.

Students mentored include Ph.D. candidates at the University of Zurich. His lab investigates lipoprotein synthesis pathways and host immunity interactions, with implications for tuberculosis and nontuberculous mycobacteria therapies.